Table 4: Patient Survival and Graft Survival Rates - University of Pittsburg.
| Actuarial survival rate | 1 year | 5 year | 10 year |
|---|---|---|---|
| 1990-2001 | |||
| KM Patient survival for entire cohort (155 patients) | 75% | 54% | 42% |
| KM Graft survival | ? | ? | |
| Patient survival since 1994 (93 patients) | 78% | 63% (p=0.03) | |
| Survival of patients treated with daclizumab (48) | 86% (p=0.3) | ||
| Survival of bone marrow augmented patients (38) | 79% | 74% | |
| 1990-1998 | |||
| Overall cumulative patient survival (109 patients) | 72% | 48% | |
| Overall cumulative graft survival (115 grafts) | 64% | 40% |